Latest filing published 16 Jul 2026 for Encompass Health Corp, €31k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Christopher R. Reidy, listed as board member, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Encompass Health Corp, Embecta Corp. and Becton Dickinson & Co. Between 1 October 2021 and 16 July 2026, the trades on record add up to 36 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 16 July 2026: a share grant of €31k, in Encompass Health Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 36 declarations